<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>

<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">29346085</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>07</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>07</Month>
            <Day>19</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-5967</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>99-100</Volume>
                    <PubDate>
                        <MedlineDate>2018 Feb - Mar</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</Title>
                <ISOAbbreviation>J. Clin. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>67-70</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1386-6532(18)30003-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcv.2018.01.003</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">Assays that detect HIV antigen (Ag) and antibody (Ab) can be used to screen for HIV infection.</AbstractText>
                <AbstractText Label="OBJECTIVES">To compare the performance of the BioPlex 2200 HIV Ag-Ab assay and two other Ag/Ab combination assays for detection of acute HIV infection.</AbstractText>
                <AbstractText Label="STUDY DESIGN">Samples were obtained from 24 individuals (18 from the US, 6 from South Africa); these individuals were classified as having acute infection based on the following criteria: positive qualitative RNA assay; two negative rapid tests; negative discriminatory test. The samples were tested with the BioPlex assay, the ARCHITECT HIV Ag/Ab Combo test, the Bio-Rad GS HIV Combo Ag-Ab EIA test, and a viral load assay.</AbstractText>
                <AbstractText Label="RESULTS">Twelve (50.0%) of 24 samples had RNA detected only ( &gt; 40 to 13,476 copies/mL). Ten (43.5%) samples had reactive results with all three Ag/Ab assays, one sample was reactive with the ARCHITECT and Bio-Rad assays, and one sample was reactive with the Bio-Rad and BioPlex assays. The 11 samples that were reactive with the BioPlex assay had viral loads from 83,010 to &gt;750,000 copies/mL; 9/11 samples were classified as Ag positive/Ab negative by the BioPlex assay.</AbstractText>
                <AbstractText Label="CONCLUSIONS">Detection of acute HIV infection was similar for the BioPlex assay and two other Ag/Ab assays. All three tests were less sensitive than a qualitative RNA assay and only detected HIV Ag when the viral load was high. The BioPlex assay detected acute infection in about half of the cases, and identified most of those infections as Ag positive/Ab negative.</AbstractText>
                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Eshleman</LastName>
                    <ForeName>Susan H</ForeName>
                    <Initials>SH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Electronic address: seshlem@jhmi.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Piwowar-Manning</LastName>
                    <ForeName>Estelle</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Electronic address: epiwowa@jhmi.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sivay</LastName>
                    <ForeName>Mariya V</ForeName>
                    <Initials>MV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Electronic address: msivay1@jhmi.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Debevec</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Electronic address: Bdebeve1@jhmi.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Veater</LastName>
                    <ForeName>Stephanie</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Electronic address: sveater1@jhmi.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McKinstry</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Statistical Center for AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, United States. Electronic address: lamckins@scharp.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bekker</LastName>
                    <ForeName>Linda-Gail</ForeName>
                    <Initials>LG</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Desmond Tutu HIV Centre, University of Cape Town, South Africa. Electronic address: linda-gail.bekker@hiv-research.org.za.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mannheimer</LastName>
                    <ForeName>Sharon</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Harlem Hospital, Columbia University, Mailman School of Public Health, New York, NY, United States. Electronic address: Sbm20@cumc.columbia.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grant</LastName>
                    <ForeName>Robert M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of California, San Francisco Gladstone Institutes, San Francisco, CA, United States. Electronic address: rgrant@gladstone.ucsf.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chesney</LastName>
                    <ForeName>Margaret A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, School of Medicine, Univers ity of California, San Francisco, CA, United States. Electronic address: Margaret.Chesney@ucsf.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Coates</LastName>
                    <ForeName>Thomas J</ForeName>
                    <Initials>TJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for World Health, David Geffen School of Medicine, Los Angeles, CA, United States. Electronic address: tcoates@mednet.ucla.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koblin</LastName>
                    <ForeName>Beryl A</ForeName>
                    <Initials>BA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Infectious Disease Prevention, New York Blood Center, New York, NY, United States. Electronic address: bkoblin@nybc.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fogel</LastName>
                    <ForeName>Jessica M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Electronic address: jfogel@jhmi.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 AI095068</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UM1 AI069470</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P30 MH058107</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UM1 AI068619</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UM1 AI068613</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UM1 AI068617</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D023362">Evaluation Studies</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>01</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>J Clin Virol</MedlineTA>
            <NlmUniqueID>9815671</NlmUniqueID>
            <ISSNLinking>1386-6532</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015483">HIV Antibodies</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015488">HIV Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011933">Reagent Kits, Diagnostic</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000071297" MajorTopicYN="N">Acute Retroviral Syndrome</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000353" MajorTopicYN="N" Type="Geographic">Africa, Southern</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006678" MajorTopicYN="N">HIV</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015483" MajorTopicYN="N">HIV Antibodies</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015488" MajorTopicYN="N">HIV Antigens</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057230" MajorTopicYN="N">Limit of Detection</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011933" MajorTopicYN="N">Reagent Kits, Diagnostic</DescriptorName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Acute</Keyword>
            <Keyword MajorTopicYN="Y">Ag/Ab assay</Keyword>
            <Keyword MajorTopicYN="Y">BioPlex</Keyword>
            <Keyword MajorTopicYN="Y">HIV</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>12</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>01</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>1</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>7</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>1</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">29346085</ArticleId>
            <ArticleId IdType="pii">S1386-6532(18)30003-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jcv.2018.01.003</ArticleId>
            <ArticleId IdType="pmc">PMC5807223</ArticleId>
            <ArticleId IdType="mid">NIHMS934711</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Virol. 2017 Sep;94:15-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28710996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):121-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19506484</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2017 Aug 1;216(3):382-386</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28666370</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2009 Nov 06;4(11):e7702</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19893738</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin HIV AIDS. 2015 Jan;10(1):61-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25389806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2010 Oct 15;202 Suppl 2:S270-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20846033</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 Aug 28;12 (8):e0183944</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28846743</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):271-279</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28328548</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2016 Apr 04;23 (4):249-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26936099</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):111-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26761274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2009 Sep;47(9):2906-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19625478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2004 Jul 3-9;364(9428):41-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15234855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2017 Jul;92 :62-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28535437</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet HIV. 2018 Feb;5(2):e68-e78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28986029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2014 Jan;52(1):103-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24153130</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
